{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin functions in mitophagy to eliminate damaged mitochondria. The C289G mutant fails to redistribute to damaged mitochondria and induces aggregation, impairing mitophagy and contributing to Parkinson's disease pathology.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism (mitophagy dysfunction via Parkin) and links the variant to loss of function and aggregation, which are pathogenic in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses assays to measure mitophagy induction (LC3 relocation to depolarized mitochondria) and protein aggregation suppression by chaperones (HSJ1a/DNAJB2a).",
          "judgment": "Yes",
          "reasoning": "The assays directly assess Parkin's functional role in mitophagy and aggregation, which are central to the disease mechanism. These are standard approaches in Parkin-related functional studies.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type Parkin and Parkin(C289G) were compared. Controls included HSJ1a/DNAJB6 and DNAJB6 to assess rescue of mitophagy. No explicit mention of replicate counts.",
          "judgment": "No",
          "reasoning": "While wild-type and mutant controls were used, the paper does not explicitly state replicate numbers or independent experiments for the C289G variant-specific assays.",
          "next_step_or_outcome": "Proceed to Step 3b"
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Mitophagy assays (LC3 relocation) and aggregation assays are standard methods in the field for studying Parkin function.",
          "judgment": "Yes",
          "reasoning": "The assays are broadly accepted in the field for evaluating Parkin's role in mitophagy and protein aggregation. No prior validation references are cited, but the methods are standard.",
          "next_step_or_outcome": "Max PS3_supporting"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not report statistical metrics (p-values, effect sizes) or OddsPath calculations for the C289G variant.",
          "judgment": "No",
          "reasoning": "The paper does not quantify the effect size or statistical significance for the mutant's impact on mitophagy or aggregation. Control variant counts are unspecified.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_strength": "PS3_supporting",
      "final_strength_justification": "The variant causes loss of mitophagy function and aggregation, aligning with Parkin's role in Parkinson's disease. While assays are standard, lack of replicates and statistical quantification limits evidence to 'supporting' strength."
    }
  ]
}